Details of the Drug

General Information of Drug (ID: DMZ5MQM)

• Drug Name: GLPG-0555
• Synonyms: Chondrocyte differentiation-modulating therapeutics (osteoarthritis), Galapagos/GlaxoSmithKline; GT-622 modulating compounds (osteoarthritis), Galapagos/GlaxoSmithKline

Indication

Disease Entry	ICD 11	Status	REF
Osteoarthritis	FA00-FA05	Phase 1	[1]

• Cross-matching ID: TTD ID: D0N3YT

References

• [1] ClinicalTrials.gov (NCT01278095) Oral Bioavailability of GLPG0555 in Different Solid Formulations. U.S. National Institutes of Health.